is pleased to announce:

ONCOLOGIC

IMAGING COURSE
THE MSK DISEASE MANAGEMENT
TEAM APPROACH

Thursday-Saturday, May 14-16, 2015

C O N F E R E N C E LO C AT I O N

ZUCKERMAN

RESEARCH CENTER

417 East 68th Street (between First and York Avenues)

For more information and to register go to:

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

COURSE OVERVIEW
The purpose of this course is to discuss the
Memorial Sloan Kettering Cancer Centers
disease management team approach
and the latest information in the field.
Our target audience includes diagnostic
radiologists, medical oncologists, oncologic
surgeons, and radiation oncologists.
Participants will have ample opportunity
to ask questions of the faculty.

ONCOLOGIC

IMAGING COURSE
THE MSK DISEASE MANAGEMENT
TEAM APPROACH

Thursday-Saturday, May 14-16, 2015

www.mskcc.org/oncologicimaging
For more information and to register go to:

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

EDUC ATIONAL OBJECTIVES

Describe the information that multidisciplinary physicians
seek from oncologic imaging studies
Review the basic principles of oncologic imaging and their
associated pitfalls
Examine the most effective methods for diagnosis, staging,
follow-up, and interventional therapies in a wide range of
cancers
Demonstrate the synergies that result from multidisciplinary
interactions in oncologic care
Summarize methods for improving the clinical relevance and
added value of oncologic imaging reports.

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

MSK PROGR A M DIRECTOR

David M. Panicek
MD FACR

Vice Chair for Clinical Affairs

Director, Educational Programs
Attending Radiologist
Body Imaging Service
Department of Radiology

I am a board-certified diagnostic radiologist with special

expertise in the care of patients
with bone tumors and soft-tissue
sarcomas.
As an integral member of the
Bone Tumor Disease Management Team, I collaborate closely
with orthopedic surgeons, medical oncologists, and pathologists
to optimize the accurate diagnosis, treatment, and follow-up
of patients with these rare and
often difficult-to-treat tumors.

My research interests cover a

wide range of topics in oncologic imaging, often evaluating the
effectiveness of various imaging
techniques used in the diagnosis
and care of patients with cancer.
I am currently studying MR imaging and CT scanning of bone
and soft-tissue tumors. I was the
lead investigator on the National
Cancer Institute/National Institutes of Health multi-institutional
project which compared CT and
MR imaging for the staging of
musculoskeletal cancers.

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH
MSK FACULT Y
Nadeem Abu-Rustum
MD FACOG FACS
Attending Surgeon
Chief, Gynecology Service
Department of Surgery

Oguz Akin MD

Director, Body MRI

Associate Attending Radiologist
Body Imaging Service
Department of Radiology

William Alago MD

Associate Attending Radiologist

Interventional Radiology Service
Department of Radiology

Cameron Brennan MD

Associate Attending Neurosurgeon

Department of Neurosurgery
Human Oncology and Pathogenesis Program

Sandra Brennan
MBBCh BAO FRCR

Assistant Attending Radiologist

Breast Imaging Service
Body Imaging Service
Department of Radiology

Hiram Cody MD FACS

Attending Surgeon
Breast Service
Department of Surgery

Jonathan Coleman MD

Associate Attending Surgeon

Urology Service
Department of Surgery

Michael DAngelica MD

Attending Surgeon
Hepatopancreatobiliary Service
Division of General Surgical Oncology
Department of Surgery

Richard Kinh Gian Do MD PhD

Assistant Attending Radiologist
Body Imaging Service
Department of Radiology

Scott Gerst MD

Associate Attending Radiologist

Body Imaging Service
Department of Radiology

Michelle Ginsberg MD

Director, Cardiothoracic Imaging

Associate Director, Educational Programs
Attending Radiologist
Body Imaging Service
Department of Radiology

Marc Gollub MD

Director, CT
Director, GI Radiology
Attending Radiologist
Body Imaging Service
Department of Radiology

Meera Hameed MD

Attending Pathologist
Chief, Surgical Pathology Service
Molecular Diagnostics Service
Neuropathology and Autopsy Service
Department of Pathology

John Healey MD FACS

Attending Surgeon
Chief, Orthopedic Service
Department of Surgery

Andrei Holodny MD

Attending Radiologist
Chief, Neuroradiology Service
Department of Radiology

Steven Horwitz MD

Associate Attending Physician

Lymphoma Service
Division of Hematologic Oncology
Department of Medicine

Hedvig Hricak MD PhD

Chair, Department of Radiology

Attending Radiologist
Body Imaging Service

Sasan Karimi MD

Director, MSK- 55th Street Radiology

Training Program Director
Associate Attending Radiologist
Neuroradiology Service
Department of Radiology

Seth Katz MD

Assistant Attending Radiologist

Body Imaging Service
Department of Radiology

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH
MSK FACULT Y
Yulia Lakhman MD

Hilda Stambuk MD

Jason Lewis MSc PhD

Janice Sung MD

Assistant Attending Radiologist

Body Imaging Service
Department of Radiology
Attending Radiochemist
Chief, Radiochemistry and
Imaging Sciences Service
Department of Radiology

Lorenzo Mannelli MD PhD

Assistant Attending Radiologist

Body Imaging Service
Molecular Imaging & Therapy Service
Department of Radiology

Harpreet Pannu MD

Associate Attending Radiologist

Body Imaging Service
Department of Radiology

Andrew Plodkowski MD

Assistant Attending Radiologist

Body Imaging Service
Department of Radiology

Nabil Rizk MD

Associate Attending Surgeon

Thoracic Service
Department of Surgery

Evis Sala MD PhD

Chief, Body Imaging Service

Attending Radiologist
Department of Radiology

Heiko Schder MD

Attending Physician
Molecular Imaging & Therapy Service
Department of Radiology

Attending Radiologist
Neuroradiology Service
Department of Radiology
Assistant Attending Radiologist
Breast Imaging Service
Department of Radiology

Elizabeth Sutton MD

Assistant Attending Radiologist

Breast Imaging Service
Department of Radiology

Jean Torrisi MD

Attending Radiologist
Body Imaging Service
Department of Radiology

Gary Ulaner MD PhD

Assistant Attending Radiologist

Molecular Imaging & Therapy Service
Department of Radiology

Hebert Alberto Vargas MD

Assistant Attending Radiologist

Body Imaging Service
Molecular Imaging & Therapy Service
Department of Radiology

Wolfgang Weber MD

Attending Physician
Chief, Molecular Imaging & Therapy Service
Department of Radiology

Michael Zelefsky MD

Attending Radiation Oncologist

Chief, Brachytherapy Service
Department of Radiation Oncology

Karen Schupak MD

Director, Department of Radiation Oncology

Regional Programs
Attending Radiation Oncologist
Department of Radiation Oncology

Stephen Solomon MD

Chief, Interventional Radiology Service

Attending Radiologist
Department of Radiology

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

Thursday, May 14 ( Morning )

7:30am
8:00am

REGISTRATION

Welcome and Program Introduction

David Panicek MD FACR

OVERVIEW OF ONCOLOGIC IMAGING

8:15am

Oncologic Imaging 2020

8:35am

Molecular Imaging:
A Glimpse into the Future

Hedvig Hricak MD/PhD

Wolfgang Weber MD

8:55am

Principles of Oncologic
Imaging and Reporting
David Panicek MD FACR

9:15am

Interventional Oncology: Scope and Trends

9:35am

Panel Discussion: How Safe is Radiation in Oncologic

Imaging?

Stephen Solomon MD

PANEL: Larry Dauer PhD, Hricak, Panicek, Solomon, Weber

10:00am

BREAK

HEAD / NECK / SPINE

10:30am

Brain Tumors:
A Neurosurgeons Perspective
Cameron Brennan MD

10:50am

Brain Tumors: Imaging

Physiology and Genetics
Andrei Holodny MD

11:10am
11:30am

Head and Neck Tumors

Hilda Stambuk MD

Imaging of the Post-therapeutic Spine

Sasan Karimi MD

11:50am

Multidisciplinary Panel Discussion

12:15pm

LUNCH (on own)

PANEL: Brennan, Holodny, Karimi, Stambuk

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

Thursday, May 14 ( Afternoon )

CHEST
1:45pm

Lung Cancer: A Surgeons Perspective

Nabil Rizk MD

2:05pm

Imaging of Lung Cancer

2:25pm

PET / CT Imaging of Lung Cancer

2:45pm

Esophageal Cancer:
CT and PET/CT

Andrew Plodkowski MD
Heiko Schder MD

Wolfgang Weber MD

3:05pm

BREAK

3:25pm

Pulmonary Infections in the

Oncologic Patient

Michelle Ginsberg MD
3:45pm

Complications of Chemotherapy:
Importance for the Oncologic Imager
Jean Torrisi MD

4:05pm
4:25pm

Ablation Therapy in Lung Cancer

William Alago MD

Multidisciplinary Panel Discussion, and

Debate on Lung Cancer Screening

PANEL: Alago, Ginsberg, Plodkowski, Rizk, Schder, Torrisi, Weber

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

Friday, May 15 ( Morning )

HEPATOPANCREATOBILIARY
AND GENITOURINARY
8:00am

Hepatobiliary Tumors: A Surgeons Perspective

Michael DAngelica MD

8:20am

Liver Tumors

8:40am

Biliary Tumors

9:00am

Scott Gerst MD

Richard Kinh Gian Do MD PhD

Primary Pancreatic Adenocarcinoma

Lorenzo Mannelli MD/PhD

9:20am

Cystic Tumors of Pancreas

9:40am

Multidisciplinary Panel Discussion

10:00am

BREAK

10:30am

Renal Cancer: A Surgeons Perspective

10:50am

Seth Katz MD

PANEL: DAngelica, Do, Gerst, Katz, Mannelli

Jonathan Coleman MD

Imaging Primary Renal Cell Cancer

Oguz Akin MD

11:10am

Imaging of Bladder Cancer

11:30am

Multidisciplinary Panel Discussion

12:00pm

LUNCH (on own)

Hebert Alberto Vargas MD

PANEL: Akin, Coleman, Vargas

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

Friday, May 15 ( Afternoon )

PROSTATE and GASTROINTESTINAL

1:30pm

Prostate Cancer:
What the Radiation Oncologist Requires from Imaging

Michael Zelefsky MD
1:50pm
2:10pm
2:30pm

Imaging and Staging of Prostate Cancer

Hedvig Hricak MD/PhD

Imaging of the Treated Prostate

Hebert Alberto Vargas MD

Colorectal Cancer: Screening, Diagnosis and Staging

Naomi Campbell MD

2:50pm

BREAK

3:20pm

Rectal Cancer: Post-Treatment Assessment and

the Role of Imaging in Non-Operative Management

Marc Gollub MD
3:40pm
4:00pm

Overview of Tumor Response Assessment Criteria

David Panicek MD

The Peritoneal Cavity & Subperitoneal Space:

An Important Conduit for Disease
Harpreet Pannu MD

4:20pm

Multidisciplinary Panel Discussion, and Debates on

Prostate MRI, Colorectal Cancer Screening

PANEL: Campbell, Gollub, Hricak, Panicek, Pannu, Vargas, Zelefsky

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

Saturday, May 16

( Morning )

GYNECOLOGIC SYSTEM,
LYMPHOMA, AND MRI/PET

8:00am

Gynecologic Malignancies:
A Surgeons Perspective

Nadeem Abu-Rustum MD FACOG FACS

8:20am

Ovarian Cancer

8:40am

Cervical Cancer

9:00am
9:20am

Hedvig Hricak MD/PhD

Yulia Lakhman MD

Endometrial Cancer

Evis Sala MD/PhD

Imaging Techniques and Their Impact on

Radiation Therapy Treatment Design
Karen Schupak MD

9:40am

BREAK

10:10am

Lymphoma: A Medical Oncologists Perspective

10:30am

SUV 101

Steven Horwitz MD

Wolfgang Weber MD

10:50am Lymphoma

Heiko Schder MD

11:10am

Enhancing the Image: New Strategies

11:30am

Multidisciplinary Panel Discussion, and

Debate on PET/CT and MRI/PET

Jason Lewis MSc PhD

PANEL: Abu-Rustum, Horwitz, Hricak, Lakhman, Lewis,

Sala, Schder, Schupak, Weber

12:00pm

LUNCH (on own)

www.mskcc.org/oncologicimaging

SCIENTIFIC AGENDA:
ONCOLOGIC IMAGING: THE MSK
DISEASE MANAGEMENT TEAM APPROACH

Saturday, May 16

( Afternoon )

BREAST
1:30pm
1:50pm
2:10pm
2:30pm
2:50pm

Breast Cancer: A Surgeons Perspective

Hiram Cody MD FACS

Staging of Breast Cancer: Anatomy vs. Biology

Elizabeth Sutton MD

PET / CT in Breast Cancer

Gary Ulaner MD PhD

Breast Density and High Risk Screening

Janice Sung MD

Percutaneous Breast Biopsy High Risk Lesions.

Do we excise everything?

SandraBrennan MBBCh
3:10pm

Multidisciplinary Panel Discussion, and Debate:

Do we need to remove all disease in breast cancer?

PANEL: Brennan, Cody, Sung, Sutton, Ulaner

3:40pm

BREAK

4:00pm

Bone Tumors: A Surgeons Perspective

4:20pm
4:40pm

John Healey MD FACS

Characterizing Bone Tumors at MRI

David Panicek MD FACR

Radiologic-Pathologic Correlation of
Common Bone Tumors

Meera Hameed MD
5:00pm

Multidisciplinary Panel Discussion

5:30pm

ADJOURN

PANEL: Hameed, Healey, Panicek

www.mskcc.org/oncologicimaging

REGISTRATION
EARLY*

GENERAL

$650

$750

$325

Physicians (MDs, PhDs, DOs)

Physicians-in-Training and Health Care

Professionals (Includes RNs, APNs, Technologists)

* Postmarked by 3/30/2015

Registration fee includes an electronic syllabus and other related hand-out materials,
continental breakfast and refreshment breaks. Please let us know if we can assist you.

To register to attend please go to:

www.mskcc.org/oncologicimaging
Or contact:

OFFICE OF CONTINUING MEDICAL EDUCATION

Memorial Sloan Kettering Cancer Center
633 Third Avenue, 12th Floor, New York, New York 10017

(646) 227-2025 brodheap@mskcc.org

COURSE DESIGN

FACULTY DISCLOSURE

This course is comprised of lectures

and interactive audience participation
encouraging the intellectual exchange
of ideas between faculty and
participants.

It is the policy of MSK to make every

effort to insure balance, independence,
objectivity, and scientific rigor in all
continuing medical education activities
which it sponsors as an ACCME
accredited provider. In accordance
with ACCME guidelines and standards,
all faculty participating in an activity
sponsored by MSK are expected
to disclose any significant financial
interest or other relationship with the
manufacturer(s) of any commercial
product(s) and/or provider(s) of
commercial services which are discussed
by the faculty members in an educational
presentation. As required by the
ACCME, when an unlabeled use of a
commercial product or an investigational
use not yet approved for any purpose is
discussed during an educational activity,
MSK requires the speaker to disclose
that the product is not labeled for the
use under discussion or that the product
is still investigational.

EVALUATION

A course evaluation survey sent out

electronically will provide attendees with
the opportunity to review the sessions
and the speakers and to identify future
educational needs.
ACCREDITATION STATEMENT

MSK is accredited by the Accreditation

Council for Continuing Medical Education
(ACCME) to provide continuing medical
education for physicians.
AMA CREDIT DESIGNATION STATEMENT

MSK designates this live activity for a

maximum of 20.0 AMA PRA Category
1 Credits. Physicians should only claim
credit commensurate with the extent of
their participation in the activity.
The AMA has determined that physicians
not licensed in the United States but who
participate in this CME activity are eligible
for 20.0 AMA PRA Category 1 Credits.

OUTCOMES MEASUREMENT SURVEY

Six months after the end of the course an

Outcomes Measurement Survey will be
sent to all participants to help us determine
what positive impacts have been made on
participant practice as a result of the course.